No support for premature central nervous system aging in HIV-1 when measured by cerebrospinal fluid phosphorylated tau (p-tau)

References

• Deeks SG. HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med 2011; 62:141-55; PMID:21090961; https://doi.org/10.1146/annurev-med-042909-093756
   PubMed Web of Science ®Google Scholar
• Budka H. Neuropathology of human immunodeficiency virus infection. Brain Pathol 1991; 1:163-75; PMID:1669705; https://doi.org/10.1111/j.1750-3639.1991.tb00656.x
   PubMed Web of Science ®Google Scholar
• Clifford DB, Ances BM. HIV-associated neurocognitive disorder. Lancet Infect Dis 2013; 13:976-86; PMID:24156898; https://doi.org/10.1016/S1473-3099(13)70269-X
   PubMed Web of Science ®Google Scholar
• Portegies P, de Gans J, Lange JM, Derix MM, Speelman H, Bakker M, Danner SA, Goudsmit J. Declining incidence of AIDS dementia complex after introduction of zidovudine treatment. BMJ 1989; 299:819-21; PMID:2510843; https://doi.org/10.1136/bmj.299.6703.819
   PubMed Web of Science ®Google Scholar
• Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, Cleary P. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 1988; 239:586-92; PMID:3277272; https://doi.org/10.1126/science.3277272
   PubMed Web of Science ®Google Scholar
• Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007; 69:1789-99; PMID:17914061; https://doi.org/10.1212/01.WNL.0000287431.88658.8b
   PubMed Web of Science ®Google Scholar
• Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 2010; 75:2087-96; PMID:21135382; https://doi.org/10.1212/WNL.0b013e318200d727
   PubMed Web of Science ®Google Scholar
• Eden A, Price RW, Spudich S, Fuchs D, Hagberg L, Gisslen M. Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral therapy. J Infect Dis 2007; 196:1779-83; PMID:18190258; https://doi.org/10.1086/523648
   PubMed Web of Science ®Google Scholar
• Yilmaz A, Yiannoutsos CT, Fuchs D, Price RW, Crozier K, Hagberg L, Spudich S, Gisslen M. Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy. J Neuroinflammation 2013; 10:62; PMID:23664008; https://doi.org/10.1186/1742-2094-10-62
   PubMed Web of Science ®Google Scholar
• Ellis R, Langford D, Masliah E. HIV and antiretroviral therapy in the brain: neuronal injury and repair. Nat Rev Neurosci 2007; 8:33-44; PMID:17180161; https://doi.org/10.1038/nrn2040
   PubMed Web of Science ®Google Scholar
• Kaul M, Lipton SA. Mechanisms of neuroimmunity and neurodegeneration associated with HIV-1 infection and AIDS. J Neuroimmune Pharmacol 2006; 1:138-51; PMID:18040780; https://doi.org/10.1007/s11481-006-9011-9
   PubMed Web of Science ®Google Scholar
• Hagberg L, Cinque P, Gisslen M, Brew BJ, Spudich S, Bestetti A, Price RW, Fuchs D. Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection. AIDS Res Ther 2010; 7:15; PMID:20525234; https://doi.org/10.1186/1742-6405-7-15
   PubMed Web of Science ®Google Scholar
• Price RW, Peterson J, Fuchs D, Angel TE, Zetterberg H, Hagberg L, Spudich S, Smith RD, Jacobs JM, Brown JN, et al. Approach to cerebrospinal fluid (CSF) biomarker discovery and evaluation in HIV infection. J Neuroimmune Pharmacol 2013; 8:1147-58; PMID:23943280; https://doi.org/10.1007/s11481-013-9491-3
   PubMed Web of Science ®Google Scholar
• Jessen Krut J, Mellberg T, Price RW, Hagberg L, Fuchs D, Rosengren L, Nilsson S, Zetterberg H, Gisslen M. Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients. PLoS One 2014; 9:e88591; PMID:24523921; https://doi.org/10.1371/journal.pone.0088591
   PubMed Web of Science ®Google Scholar
• Gisslen M, Krut J, Andreasson U, Blennow K, Cinque P, Brew BJ, Spudich S, Hagberg L, Rosengren L, Price RW, et al. Amyloid and tau cerebrospinal fluid biomarkers in HIV infection. BMC Neurol 2009; 9:63; PMID:20028512; https://doi.org/10.1186/1471-2377-9-63
   PubMed Web of Science ®Google Scholar
• Clifford DB, Fagan AM, Holtzman DM, Morris JC, Teshome M, Shah AR, Kauwe JS. CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease. Neurology 2009; 73:1982-7; PMID:19907013; https://doi.org/10.1212/WNL.0b013e3181c5b445
   PubMed Web of Science ®Google Scholar
• Peterson J, Gisslen M, Zetterberg H, Fuchs D, Shacklett BL, Hagberg L, Yiannoutsos CT, Spudich SS, Price RW. Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection. PLoS One 2014; 9:e116081; PMID:25541953; https://doi.org/10.1371/journal.pone.0116081
   PubMed Web of Science ®Google Scholar
• Hampel H, Teipel SJ. Total and phosphorylated tau proteins: evaluation as core biomarker candidates in frontotemporal dementia. Dement Geriatr Cogn Disord 2004; 17:350-4; PMID:15178952; https://doi.org/10.1159/000077170
   PubMed Web of Science ®Google Scholar
• Lee DC, Rizer J, Selenica ML, Reid P, Kraft C, Johnson A, Blair L, Gordon MN, Dickey CA, Morgan D. LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice. J Neuroinflammation 2010; 7:56; PMID:20846376; https://doi.org/10.1186/1742-2094-7-56
   PubMed Web of Science ®Google Scholar
• Sy M, Kitazawa M, Medeiros R, Whitman L, Cheng D, Lane TE, Laferla FM. Inflammation induced by infection potentiates tau pathological features in transgenic mice. Am J Pathol 2011; 178:2811-22; PMID:21531375; https://doi.org/10.1016/j.ajpath.2011.02.012
   PubMed Web of Science ®Google Scholar
• Sjogren M, Vanderstichele H, Agren H, Zachrisson O, Edsbagge M, Wikkelso C, Skoog I, Wallin A, Wahlund LO, Marcusson J, et al. Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values. Clin Chem 2001; 47:1776-81; PMID:11568086
   PubMed Web of Science ®Google Scholar
• Krut JJ, Zetterberg H, Blennow K, Cinque P, Hagberg L, Price RW, Studahl M, Gisslen M. Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections. J Neurol 2012; 260:620-6; PMID:23052602
   PubMed Web of Science ®Google Scholar
• Gartner S, Liu Y. Insights into the role of immune activation in HIV neuropathogenesis. J Neurovirol 2002; 8:69-75; PMID:11935459; https://doi.org/10.1080/13550280290049525
   PubMed Web of Science ®Google Scholar
• Andersson L, Blennow K, Fuchs D, Svennerholm B, Gisslen M. Increased cerebrospinal fluid protein tau concentration in neuro-AIDS. J Neurol Sci 1999; 171:92-6; PMID:10581374; https://doi.org/10.1016/S0022-510X(99)00253-1
   PubMed Web of Science ®Google Scholar
• Brew BJ, Pemberton L, Blennow K, Wallin A, Hagberg L. CSF amyloid beta42 and tau levels correlate with AIDS dementia complex. Neurology 2005; 65:1490-2; PMID:16275845; https://doi.org/10.1212/01.wnl.0000183293.95787.b7
   PubMed Web of Science ®Google Scholar
• Castro KG, Ward JW, Slutsker L, Buehler JW, Jaffe HW, Berkelman RL, Curran JW. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Clin Infect Dis 1993; 17:802-10; https://doi.org/10.1093/clinids/17.4.802
   Web of Science ®Google Scholar
• Janssen RS, Cornblath DR, Epstein LG, Foa RP, McArthur JC, Price RW, Asbury AK, Beckett A, Benson DF, Bridge TP, et al. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Neurology 1991; 41:778-85; PMID:2046917; https://doi.org/10.1212/WNL.41.9.1355
   PubMed Web of Science ®Google Scholar
• Blennow K, Wallin A, Agren H, Spenger C, Siegfried J, Vanmechelen E. Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease? Mol Chem Neuropathol 1995; 26:231-45; PMID:8748926; https://doi.org/10.1007/BF02815140
   PubMedGoogle Scholar
• Vanmechelen E, Vanderstichele H, Davidsson P, Van Kerschaver E, Van Der Perre B, Sjögren M, Andreasen N, Blennow K. Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization. Neurosci Lett 2000; 285:49-52; PMID:10788705; https://doi.org/10.1016/S0304-3940(00)01036-3
   PubMed Web of Science ®Google Scholar